A detailed history of Continuum Advisory, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 16 shares of LNTH stock, worth $1,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 50 68.0%
Holding current value
$1,560
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$77.7 - $123.62 $2,641 - $4,203
-34 Reduced 68.0%
16 $1,000
Q2 2024

Jul 19, 2024

SELL
$58.87 - $83.05 $117 - $166
-2 Reduced 3.85%
50 $4,000
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $2,655 - $3,549
52 New
52 $3,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.7B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.